Review Note

Last Update: 04/17/2023 11:49 PM

Current Deck: IM ANKI::GIM1

Published

In addition to decreasing Glu levels, {{c1::SGLT2i::Class}} also causes {{c2::increased urinary excretion}} → {{c2::wt loss}}, and {{c2::↓BP}}

Ex: Empagliflozin

ENDO::Diabetes::T2DM Pharm::Antihyperglycemics::SGLT2 Source::MKSAP_19::GIM1

Deck Changes (Suggestion to move the Note to the following Deck):

Field Changes:

Tag Changes: